PREVENTION OF CEREBRAL DYSFUNCTION DURING OPEN HEART SURGERY

心脏直视手术期间预防脑功能障碍

• 批准号: 3788811
• 负责人: LAVERNE GUGINO
• 金额: --
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3788811
• 关键词: central nervous system disorders; chemoprevention; clinical trials; coronary bypass; human subject; human therapy evaluation; medical complication; neuroprotectants

This study tests the hypothesis that Investigational Drug, ID OPC-14117 prevents CNS dysfunction, a frequent consequence of cardiopulmonary bypass (CPB) procedures. This is a randomized, double- blind placebo-controlled study of patients undergoing CPB surgery.

这项研究检验了研究药物ID OPC-14117的假设 预防中枢神经系统功能障碍，这是心肺疾病的常见后果 体外循环(CPB)手术。这是一个随机的、双盲的 体外循环手术患者的安慰剂对照研究。